Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

The clinical goals of intravenous lipid emulsions (ILEs) have changed since their initial development. In the past, 100% soybean oil was used to provide energy and prevent an essential fatty acid deficiency. Now, different oil sources are used with the goal of improving nutritional status and preventing common neonatal comorbidities. We now have a better understanding of specific ILE constituents, namely, fatty acids, vitamin E, and phytosterols, and how these components contribute to complications such as intestinal failure-associated liver disease. This review addresses the development and composition of different ILEs and summarizes how individual ILE ingredients affect infant metabolism and health. Copyright © 2020 by the American Academy of Pediatrics.

Citation

Kara L Calkins, Daniel T Robinson. Intravenous Lipid Emulsions in the NICU. NeoReviews. 2020 Feb;21(2):e109-e119

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 32005721

View Full Text